Arkivoc 2019, vi, 0-0
Chang, M.-Y. et al.
153.1, 140.6, 128.8, 125.6, 119.3, 113.3, 112.5, 109.9, 107.7, 59.4, 55.3, 55.0, 50.1, 42.8, 31.1, 30.4, 30.2; GC-
MS: m/z (%) 297 (65) [M + H+], 282 (45), 267 (12), 236 (10), 158 (24), 144 (23), 91 (10).
o
5-Chloro-3-(4-chlorophenyl)-1,1,3-trimethylindan (4e).7 Colorless solid (102 mg, 67%); mp 81-82 C (from
hexanes and EtOAc); HRMS (ESI-TOF) m/z: [M + H]+ calcd for C18H19Cl2 305.0864, found 305.0866; 1H NMR (400
MHz, CDCl3): δ 7.27-7.20 (m, 3H), 7.13-7.07 (m, 3H), 7.04 (d, J 2.0, 1H), 2.37 (d, J 12.8, 1H), 2.20 (d, J 12.8, 1H),
1.65 (s, 3H), 1.32 (s, 3H), 1.03 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 150.6, 150.3, 148.7, 132.4, 131.5, 128.2
(2×), 128.0 (2×), 127.7, 124.9, 123.9, 59.2, 50.5, 42.6, 30.59, 30.57, 30.3.
2,4-Di(4-chlorophenyl)-4-methyl-1-pentene (4e-1).42 Colorless oil (12 mg, 8%); HRMS (ESI-TOF) m/z: [M +
H]+ calcd for C18H19Cl2 305.0864, found 305.0868; 1H NMR (400 MHz, CDCl3): δ 7.19-7.15 (m, 6H), 7.12-7.08 (m,
2H), 5.12 (d, J 1.6, 1H), 4.08 (d, J 0.4, 1H), 2.77 (s, 2H), 1.22 (s, 6H); 13C NMR (100 MHz, CDCl3): δ 147.3, 145.4,
141.5, 132.7, 131.3, 128.1 (2×), 127.79 (2×), 127.76 (2×), 127.4 (2×), 117.5, 49.7, 38.4, 28.8 (2×).
5-Fluoro-3-(4-fluorophenyl)-1,1,3-trimethylindan (4f).18 Colorless oil (90 mg, 66%); HRMS (ESI-TOF) m/z: [M
1
+ H]+ calcd for C18H19F2 273.1455, found 273.1456; H NMR (400 MHz, CDCl3): δ 7.15-7.11 (m, 3H), 7.00-6.91
(m, 3H), 6.76 (dd, J 2.4, 9.2, 1H), 2.39 (d, J 12.8, 1H), 2.22 (d, J 13.2, 1H), 1.66 (s, 3H), 1.33 (s, 3H), 1.04 (s, 3H);
13C NMR (100 MHz, CDCl3): δ 162.3 (d, J 242.6), 161.0 (d, J 243.3), 150.7 (d, J 6.8), 147.5 (d, J 2.3), 146.1 (d, J
3.0), 128.0 (d, J 7.6, 2×), 123.7 (d, J 8.3), 114.7 (d, J 20.4, 2×), 114.4 (d, J 22.7), 111.4 (d, J 21.2), 59.6, 50.2,
42.4, 30.8, 30.7, 30.4.
2,4-Di(4-fluorophenyl)-4-methyl-1-pentene (4f-1).42 Colorless oil (20 mg, 15%); HRMS (ESI-TOF) m/z: [M +
H]+ calcd for C18H19F2 273.1455, found 273.1458; 1H NMR (400 MHz, CDCl3): δ 6.85-6.76 (m, 4H), 6.56-6.49 (m,
4H), 4.74 (d, J 1.6, 1H), 4.44 (d, J 0.8, 1H), 2.43 (s, 2H), 0.88 (s, 6H); 13C NMR (100 MHz, CDCl3): δ 161.9 (d, J
244.1), 160.8 (d, J 242.6), 145.6, 144.5, 139.1, 128.0 (d, J 7.6, 2×), 127.4 (d, J 7.6, 2×), 116.9, 114.7 (d, J 21.2,
2×), 114.3 (d, J 20.5, 2×), 50.1, 38.5, 29.0 (2×).
5-Fluoro-1-(3-fluorophenyl)-1,3,3-trimethylindan (4g). Colorless oil (83 mg, 61%); HRMS (ESI-TOF) m/z: [M +
H]+ calcd for C18H19F2 273.1455, found 273.1457; 1H NMR (400 MHz, CDCl3): δ 7.23-7.17 (m, 1H), 7.05 (d, J 8.4,
1H), 7.04 (d, J 8.4, 1H), 6.97-6.91 (m, 2H), 6.88-6.82 (m, 2H), 2.41 (d, J 13.2, 1H), 2.22 (d, J 13.2, 1H), 1.65 (s,
3H), 1.33 (s, 3H), 1.02 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 164.0 (d, J 242.6), 162.7 (d, J 243.3), 154.5 (d, J 6.8),
153.6 (d, J 5.3), 143.4 (d, J 3.0), 129.4 (d, J 8.3), 125.9 (d, J 8.4), 122.2 (d, J 3.0), 113.9 (d, J 19.7), 113.7 (d, J
19.0), 112.4 (d, J 20.5), 109.5 (d, J 21.2), 59.3, 50.3, 42.9, 30.9, 30.4, 30.1.
2,4-Di(3-fluorophenyl)-4-methyl-1-pentene (4g-1). Colorless oil (24 mg, 18%); HRMS (ESI-TOF) m/z: [M + H]+
calcd for C18H19F2 273.1455, found 273.1455; 1H NMR (400 MHz, CDCl3): δ 7.18-7.12 (m, 2H), 7.03-7.01 (m, 1H),
6.98-6.96 (m, 1H), 6.94-6.90 (m, 1H), 6.88-6.83 (m, 2H), 6.80-6.75 (m, 1H), 5.16 (d, J 1.6, 1H), 4.84 (s, 1H), 2.78
(s, 2H), 1.24 (s, 6H); 13C NMR (100 MHz, CDCl3): δ 162.6 (d, J 242.6), 162.5 (d, J 242.6), 151.7 (d, J 8.8), 145.4 (d,
J 2.3), 138.9 (d, J 8.2), 129.4 (d, J 8.3), 129.1 (d, J 8.3), 122.1 (d, J 2.3), 121.6 (d, J 2.3), 117.9, 113.6 (d, J 20.5),
113.3 (d, J 22.0), 113.2 (d, J 21.2), 112.3 (d, J 21.2), 49.6, 38.7, 28.6 (2×).
1-(3,4-Dimethoxyphenyl)-5,6-dimethoxy-1,3,3-trimethylindan (4h).19 Colorless oil (134 mg, 75%); HRMS
1
(ESI-TOF) m/z: [M + H]+ calcd for C22H29O4 357.2066, found 357.2067; H NMR (400 MHz, CDCl3): δ 6.74-6.69
(m 4H), 6.60 (s, 1H), 3.92 (s, 3H), 3.84 (s, 3H), 3.83 (s, 3H), 3.78 (s, 3H), 2.34 (d, J 13.2, 1H), 2.17 (d, J 13.2, 1H),
1.66 (s, 3H), 1.32 (s, 3H), 1.05 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 148.7, 148.3, 148.2, 146.7, 143.9, 143.8,
140.1, 118.5, 110.38, 110.36, 107.4, 105.1, 59.7, 56.0, 55.9, 55.7 (2×), 50.3, 42.7, 30.8, 30.7, 30.4.
5-Benzo[1,3]dioxol-5-yl-5,7,7-trimethyl-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxole (4i).20 Colorless oil (126
1
mg, 78%); HRMS (ESI-TOF) m/z: [M + H]+ calcd for C20H21O4 325.1440, found 325.1438; H NMR (400 MHz,
CDCl3): δ 6.71-6.62 (m, 4H), 6.53 (s, 1H), 5.96 (d, J 1.6, 1H), 5.95 (d, J 1.2, 1H), 5.91 (d, J 2.0, 1H), 5.91 (d, J 1.6,
1H), 2.34 (d, J 13.2, 1H), 2.16 (d, J 12.8, 1H), 1.61 (s, 3H), 1.29 (s, 3H), 1.05 (s, 3H); 13C NMR (100 MHz, CDCl3): δ
Page 8
©AUTHOR(S)